As the U.S. sets new record for daily coronavirus cases, Moderna has released a preview of its COVID-19 vaccine data this week. The biotech firm has announced that its vaccine candidate is 94.5% effective and that it has an even longer shelf life in the refrigerator than previously estimated. Moderna’s vaccine can now survive for … Continue reading “Moderna Reveals its Vaccine for Coronavirus is 94.5% Effective”
Biotech & Pharma
Biotech & Pharma
Pfizer Shares Explode as Company’s COVID-19 Vaccine Proves 90% Effective
Shares of pharmaceutical giant Pfizer were soaring on Monday to a new 52-week high after…
November 10, 2020
Biotech & Pharma
AstraZeneca Says Covid-19 Vaccine Results Are Expected This Year
Pharmaceutical giant AstraZeneca announced earnings this week that may have been lackluster but Wall Street…
November 7, 2020
Biotech & Pharma
Novavax Announces Deal to Expand Facilities as Company Works on Covid-19 Vaccine Candidate
American vaccine development company Novavax announced two deals this week to expand its manufacturing and…
November 3, 2020
Biotech & Pharma
Moderna Shares Explode as Company Collects Revenue on Covid Drug
Shares of Massachusetts-based biotech company Moderna were headed higher in Thursday's trading session after the…
October 30, 2020
Biotech & Pharma
Sales for Covid-19 Drug Remdesivir Fall Short Prompting Gilead to Cut 2020 Sales Outlook
This week Gilead Sciences slashed its 2020 revenue forecast, citing lower than expected demand for…
October 30, 2020
Biotech & Pharma
Vertex Shares Drop After Company Stops Testing on Protein Deficiency Treatment
Shares of pharmaceutical company Vertex Pharmaceuticals were falling this week after the company announced that…
October 16, 2020
Biotech & Pharma
Eli Lilly Shares Soar After Company Requests FDA Clearance for Antibody Drug
Shares of Eli Lilly were on the rise on Wednesday after Wall Street learned that…
October 8, 2020
Biotech & Pharma
Bristol Myers to Acquire MyoKardia for $13 Billion
Wall Street learned this week that Bristol Myers is expanding its heart drug business with…
October 6, 2020
Biotech & Pharma
Illumina Says it Will Purchase Bezos-Backed Grail for $8B
Illumina, a global leader in genomics, announced this week that it will be acquiring the…
September 22, 2020
Biotech & Pharma
Gilead to Buy Cancer-drug Company Immunomedics for $21B
Over the weekend Gilead announced that it has agreed to purchase cancer-drug company Immunomedics for…
September 15, 2020
Biotech & Pharma
Trillium Therapeutics Shares Explode on Pfizer Investment
Shares of Trillium Therapeutics were skyrocketing over 40% on a $25 million Pfizer investment this…
September 11, 2020
Biotech & Pharma
Sarepta Therapeutics Shares Crumble After Regulators Request More Work to Be Done
Sarepta Therapeutics saw its share price dip on Thursday after regulators requested more work be…
September 11, 2020
Biotech & Pharma
AbbVie Inc. Signs $2.9 Billion Deal with China’s I-Mab
Drugmaker AbbVie Inc. has inked a deal with Chinese drug developer I-Mab to collaborate on…
September 8, 2020